Allergy and Immunology · Macon, GA
NPI
1366499246
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3964 Elnora Dr
Macon, GA, 31210
Phone (478) 477-1777
Groups this clinician bills Medicare through
Medicare paid, 2024
$741K
25,218 services
Medicare patients, 2024
152
Average age 73
Drug cost, 2024
$842K
1,492 prescriptions
Company payments, 2025
$34
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rahul K Vangala was code J2357 (injection, omalizumab, 5 mg), 22,080 times for 17 patients. In total Rahul K Vangala billed 25,218 services in 17 codes, and Medicare paid $741K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 22,080 | 17 | $29.87 | $660K |
| 95165 Treatment - Miscellaneous | Office | 830 | 22 | $10.09 | $8,374 |
| 96372 Injection Administration | Office | 473 | 27 | $9.73 | $4,600 |
| 95117 Treatment - Miscellaneous | Office | 339 | 18 | $7.36 | $2,494 |
| 99213 Office E&M - Established | Office | 176 | 117 | $48.88 | $8,603 |
| 99214 Office E&M - Established | Office | 141 | 95 | $90.37 | $13K |
| 99204 Office E&M - New | Office | 12 | 12 | $124.24 | $1,491 |
By year: 2022 $911K for 30,291 services; 2023 $811K for 26,460 services; 2024 $741K for 25,218 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rahul K Vangala prescribed most often to Medicare patients was Montelukast Sodium, with 344 prescriptions and refills. In total Rahul K Vangala wrote 1,492 Medicare prescriptions that cost $842K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 344 | 802 | 93 | $3,846 |
| Fluticasone Propionate Generic | 241 | 533 | 91 | $5,318 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 118 | 127 | 50 | $2,736 |
| Azelastine Hcl Generic | 116 | 237 | 53 | $4,911 |
| Xolair Omalizumab | 92 | 99 | Under 11 | $355K |
| Dupixent Syringe Dupilumab | 71 | 73 | Under 11 | $285K |
| Ipratropium Bromide Generic | 54 | 114 | 23 | $2,541 |
| Symbicort Budesonide/Formoterol Fumarate | 51 | 75 | Under 11 | $17K |
| Famotidine Generic | 41 | 84 | 14 | $603 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 39 | 67 | 11 | $42K |
| Epinephrine Generic | 37 | 54 | 31 | $6,669 |
| Advair Hfa Fluticasone Propion/Salmeterol | 35 | 63 | 13 | $26K |
| Hydroxyzine Hcl Generic | 31 | 51 | 17 | $393 |
| Fluticasone Propionate Hfa Fluticasone Propionate | 25 | 46 | Under 11 | $12K |
| Triamcinolone Acetonide Generic | 23 | 33 | Under 11 | $261 |
Brand drugs: 487 claims; generic drugs: 1,005 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rahul K Vangala $34 ($34 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $34.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.